Sfoglia per Rivista HAEMOPHILIA
A 10-year, randomized, clinical trial on prophylaxis vs. on-demand treatment in children with haemophilia A : the E.S.P.R.I.T. study
2008 A. Gringeri, B. Lundin, S. von Mackensen, L. Mantovani, P.M. Mannucci
The 80th anniversary of von Willebrand's disease: history, management and research
2006 A.B. Federici, E. Berntorp, C.A. Lee
A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients
2011 J. Teitel, E. Berntorp, G. Dolan, K. Fischer, A. Gringeri, C. Kessler, T. Lambert, C. Leissinger, L. Nemes, M. Shima
A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency
2008 A. Maino, I. Garagiola, A. Artoni, S. Al-Humood, F. Peyvandi
A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA) : subject demographics and safety data
2010 C. Leissinger, C. Négrier, E. Berntorp, J. Windyga, M. Serban, A. Bülent, R. Lassila, K. Kavakli, B. Zulfikar, A. Gringeri
A randomized clinical trial on prophylaxis vs. episodic treatment in children with haemophilia A : the ESPRIT study
2010 A. Gringeri, B. Lundin, S. Von Mackensen, L. Mantovani, P.M. Mannucci
A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors
2007 J. Teitel, E. Berntorp, P. Collins, R. D'Oiron, B. Ewenstein, E. Gomperts, J. Goudemand, A. Gringeri, N. Key, C. Leissinger, P. Monahan, G. Young
Acquired Von Willebrand syndrome and response to desmopressin
2018 E. Biguzzi, S.M. Siboni, F. Peyvandi
Addressing current challenges in haemophilia care: consensus recommendations of a European Interdisciplinary Working Group
2005 C.A. Ludlam, P.M. Mannucci, W.G. Powderly
Adoption of emicizumab (Hemlibra®) for hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders survey
2021 E. Krumb, K. Fijnvandraat, M. Makris, F. Peyvandi, A. Ryan, A. Athanasopoulos, C. Hermans
Ageing successfully with haemophilia : A multidisciplinary programme
2018 E. Boccalandro, M.E. Mancuso, S. Riva, D.M. Pisaniello, F. Ronchetti, E. Santagostino, F. Peyvandi, L.P. Solimeno, P.M. Mannucci, G. Pasta
Arteriovenous fistula as stable venous access in children with severe haemophilia
2010 M.E. Mancuso, L. Berardinelli
Assaying FVIII activity : one method is not enough, and never was
2014 M. Makris, F. Peyvandi
Back to the future : a recent history of haemophilia treatment
2008 P.M. Mannucci
Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease
2016 S.M. Siboni, E. Biguzzi, V. Caiani, C. Mistretta, P. Bucciarelli, F. Peyvandi
Burden of mild haemophilia A: Systematic literature review
2019 F. Peyvandi, F. Tavakkoli, D. Frame, J. Quinn, B. Kim, A. Lawal, M.C. Lee, W.Y. Wong
Bypassing agent regimens and costs for prophylaxis in patients with inhibitors
2009 A. Gringeri
Central nervous system bleeding in patients with rare bleeding disorders
2012 S. M. Siboni, E. Zanon, G. Sottilotta, D. Consonni, G. Castaman, D. Mikovic, F. Biondo, A. Tagliaferri, A. Iorio, P. M. Mannucci, F. Peyvandi
Changes in factor XIII level during pregnancy
2014 L.T. Sharief, A.S. Lawrie, I.J. Mackie, C. Smith, F. Peyvandi, R.A. Kadir
Characterization of the genetic basis of FXI deficiency in two Turkish patients
2010 E. Berber, V. Rimoldi, S. Usluer, S. Aksu, Y. Pekçelen, S.H. Çağlayan, S. Duga
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile